SMSalahuddin Mahmud

Salahuddin Mahmud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Salahuddin Mahmud has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Farhana Tasneem

    Department of Pediatrics, BIHS General Hospital, Diabetic Association of Bangladesh, Dhaka, Bangladesh

    11 shared publications
  • Syed Shafi Ahmed

    Department of Pediatric Gastroenterology, Hepatology & Nutrition, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh

    11 shared publications
  • Madhabi Baidya

    Department of Pediatric Gastroenterology, Hepatology & Nutrition, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh

    8 shared publications
  • Ahmed Rashidul Hasan

    Department of Pediatric Gastroenterology, Hepatology & Nutrition, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh

    7 shared publications
  • Jahida Gulshan

    7 shared publications
  • Tanzila Farhana

    Department of Pediatric Gastroenterology, Hepatology & Nutrition, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh

    7 shared publications

Latest Publications

  • Open Access

    Effectiveness and safety of sofosbuvir/velpatasvir in chronic hepatitis C virus infection of Bangladeshi children

    by Salahuddin Mahmud, Belayet Hossain, Emdadul Haque, Madhabi Baidya, Rafia Rashid, Ahmed Rashidul Hasan, Tanzila Farhana, Farhana Tasneem, Syed Shafi Ahmed

    Background: We currently advise all pediatric patients with hepatitis C virus (HCV) infection to take oral direct-acting antivirals (DAA), especially pan-genotypic medications. This study looks at how well, safely, and tolerably sofosbuvir-velpatasvir (SOF/VEL) combination therapy works for kids and teens in Bangladesh who have chronic HCV infection. Material and methods: The study was prospective and carried out from January 2022 to July 2024. Three -to-18-year-olds who tested positive for HCV by polymerase chain reaction (PCR) were recruited using sequential non-probability sampling. Clinical characteristics were documented, and investigations were conducted. Every patient received SOF-VEL (150/37.5 mg for < 17 kg, 200/50 mg for 17 − < 30 kg, and 400/100 mg for ≥ 30 kg) for 12 weeks. All children were subjected to clinical and laboratory monitoring on a 4-weekly basis. Results: The male–female ratio was 1.2:1, and the mean age was 11.22 ± 2.76 years. Thirty-eight patients (92.7%) had a sustained virological response (SVR), which means that their HCV PCR test was negative even 12 weeks after treatment. Three patients (7.3%) exhibited unresponsiveness or virological failure, as positive PCR results showed. After treatment, patients’ biochemical (hepatic enzymes with serum bilirubin) and clinical (jaundice, dark urine, abdominal pain, and hepatomegaly) conditions got a lot better. Almost half of the study participants said the medicine was well tolerated and had no negative effects. The most prevalent adverse effects in 6–18-year-olds were headache (23.7%), nausea with vomiting (13.2%), fatigue (7.9%), vomiting with diarrhea (33.3%), and rhinorrhea (33.3%) in the 3–5-year age group. The majority of side effects were minor and were treated symptomatically. Conclusion: The SOF/VEL pan-genotypic regimen is very efficacious and well tolerated for treating chronic HCV infection in children, with no major side effects.


  • Open Access

    Clinicopathological and bacteriological profile of neonatal sepsis: a tertiary centre experience from Bangladesh

    by Farhana Tasneem, Shafayat Mohammad Imteaz, Tanzila Farhana, Ahmed Rashidul Hasan, Emdadul Haque, Salahuddin Mahmud, Mohammad Monir Hossain

    Introduction: Neonatal sepsis is a primary cause of newborn hospitalization, morbidity, and mortality. Common newborn sepsis symptoms are widely documented. Bacterial and non-bacterial sepsis in neonates may have different clinical presentations and laboratory characteristics. Again, newborn sepsis bacteria vary by region. Objectives: This study investigated the current etiology of neonatal sepsis and the clinicopathological distinctions between bacterial and non-bacterial sepsis. Materials & methods: This cross-sectional observational study was conducted in Bangladesh Shishu Hospital & Institute’s [former Dhaka Shishu (Children) Hospital] SCBU and NICU wards from May 2013 to June 2014. The study included 597 infants of both sexes who were diagnosed with clinical sepsis upon admission. We collected clinical and pathological data in all instances. Blood culture and susceptibility testing isolated and identified the microbial organism. Results: After cultivation, only 20.6% of organisms were identified. The majority of bacteria were Klebsiella (30/63). Most identified Gram-negative bacteria were susceptible to Meropenem (100%), followed by Imipenem (75%) and Cefepime (75%). E. coli was the most delicate. All isolated S. aureus were vancomycin-sensitive (100%). Nearly all bacteria were resistant to ampicillin (93.7%), gentamicin (93.7%), and third-generation cephalosporins. Clinical characteristics of neonatal bacterial sepsis include lethargy (85.7%), poor feeding (81.0%), hyperthermia (71.4%), hypoperfusion (66.7%), and jaundice (66.7%). In bacterial sepsis, hemoglobin, lymphocyte, and platelet levels were significantly lower (p<0.05), whereas neutrophil and CRP levels were significantly greater (p<0.05). Conclusion: Klebsiella dominates neonatal sepsis. The most sensitive antibiotics were meropenem and imipenem. Almost all gram-negative bacteria except E. coli were ampicillin, gentamicin, and third-generation cephalosporin-resistant. Bacterial sepsis caused greater lethargy, poor eating, heat, hypoperfusion, and jaundice. In bacterial sepsis, ANC, neutrophil, and CRP were greater, and hemoglobin, lymphocyte, and platelet were lower.

  • Open Access

    Endoscopic management of ingested foreign bodies in children: A tertiary center experience in Bangladesh

    by Salahuddin Mahmud, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Jahangir Alam, Syed Shafi Ahmed


  • Open Access

    Efficacy and Safety of Valganciclovir in Congenital Cytomegalovirus Infection with Isolated Intrahepatic Cholestasis: A Randomized Controlled Trial

    by Salahuddin Mahmud, Tanzila Farhana, Ataul Mustufa Anik, Fayaza Ahmed, Mashud Parvez, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Mohammad Jahangir Alam, et al.

    Mahmud S, et al. Pediatr Gastroenterol Hepatol Nutr. 2024 Sep;27(5):298-312. https://doi.org/10.5223/pghn.2024.27.5.298


  • Open Access

    Colonoscopic polypectomy of juvenile polyps in children: Experience from a tertiary centre of Bangladesh

    by Salahuddin Mahmud, Mashud Parvez, Madhabi Baidya, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Jahangir Alam, Syed Shafi Ahmed


  • Open Access

    Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection

    by Salahuddin Mahmud, Jahida Gulshan, Belayet Hossain, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Mohammed Reaz Mobarak, Jahangir Alam, et al.


  • Open Access

    Spectrum of Colonoscopy in Children: A Tertiary Centre Experience from Bangladesh

    by Salahuddin Mahmud, Mashud Parvez, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Nafis Fatema Asha, Jahangir Alam, Syed Shafi Ahmed

    Background: Pediatric colonoscopy is a safe, sensitive and crucial tool for diagnosing as well as treating children with lower gastrointestinal diseases. In resource-limited countries like Bangladesh, the practice of pediatric colonoscopy remains rudimentary, lacking in trained professionals and appropriate instrumentation. Objectives: The aim of the study was to find out the indications, common colonoscopic findings along with histopathologic evaluation and immediate post procedure complications of colonoscopy in children. Methods: This was a retrospective study; the records of all the patients whose age was less than 18 years and who underwent colonoscopy from January 2017 to December 2021 were studied. Results: Among the total of 196 children (8.23±4.12), the most common indications were lower gastrointestinal bleeding (LGIB) in 107 (54.6%) patients followed by chronic diarrhea in 33 (16.8%), recurrent abdominal pain (RAP) in 16 (8.2%), follow up Inflammatory bowel diseases (IBD) in 14 (7.1%), chronic constipation, weight loss, recurrent oral ulcer, intestinal tuberculosis (TB) and melena. The most common pathologic findings were polyps in 81 (61.4%) children followed by non-specific colitis in 19 (14.4%), IBD in 17 (12.9%) and infectious colitis in 09 (6.8%) cases. Minor adverse events occurred in only 2.0% of children. Conclusion: The commonest indication for pediatric colonoscopy was LGIB and the most common findings were colonic polyps. Pediatric colonoscopy is safe and effective diagnostic as well as therapeutic option for lower GI diseases. DS (Child) H J 2021; 38(1): 8-16


  • Open Access

    Spectrum of Upper GI Endoscopy in Children: A Tertiary Centre Experience from Bangladesh

    by Salahuddin Mahmud, Jahida Gulshan, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Dilruba Begum, Nafis Fatema Asha, Syed Shafi Ahmed

    Background: Upper gastrointestinal endoscopy is an essential, safe and sensitive investigation for diagnosing pediatric gastrointestinal diseases. In resource-limited countries like Bangladesh, the practice of pediatric endoscopy remains rudimentary, lacking in trained pediatric endoscopists and appropriate-sized endoscopes. There is limited study on paediatric upper GI endoscopy in our country. Objectives: The aim of the study was to find out the indications, common endoscopic findings and immediate post procedure complication of UGI endoscopy in children. Methods: This is a retrospective study; the records of all the patients whose age is less than 18 years and who underwent endoscopy in the last 6 years were studied. Results: Among the total of 384 children (age Conclusion: The commonest indication for Pediatric UGI endoscopy was recurrent abdominal pain and the commonest endoscopic feature was gastritis. No significant post procedure complication was noted in the study. DS (Child) H J 2021; 37(2): 123-128


  • Open Access

    Outcome of Wilson’s disease in Bangladeshi children: a tertiary center experience

    by Salahuddin Mahmud, Jahida Gulshan, Madhabi Baidya, Rafia Rashid, Farhana Tasneem, Ahmed Rashidul Hasan, Tanzila Farhana, Syed Shafi Ahmed

    Background: Wilson disease (WD) is an inherited disorder of copper metabolism commonly involving the liver, cornea, and brain. Its incidence is increasing day by day worldwide. Early diagnosis and prompt treatment are the key for best outcome. Material and methods: A cross-sectional descriptive study was done from January 2014 to December 2019. Sixty children of both genders between 3 and 18 years were diagnosed by clinical and laboratory profile meeting selected criteria. Results: Mean age was 8.42 ± 2.6 years and male female ratio was 1.5:1. Consanguinity of marriage was found in 38.3% cases. Seventy percent of cases were hepatic, 16.7% were neuropsychiatric, 5.0% were hepatic with neuropsychiatric, and 8.3% cases were manifested asymptomatically. Asymptomatic and hepatic WD were reported between 3 and 10 years and most of the neuropsychiatric and hepatic with neuropsychiatric manifested after 10 years of age. More than 50% cases improved, a little more than 20% children died, 18.4% were unchanged and 6.6% were hepatic added neuropsychiatric manifestations. Most of the asymptomatic (100%) and hepatic (61.9%) cases improved. High mortality was found with 76.9% cases of acute liver failure (ALF), 7.7% case of chronic liver disease (CLD) and 25% cases of CLD with portal hypertension (CLD and PH). Most of the neuropsychiatric cases (90.0%), and approximately two-third (66.6%) of hepatic with neuropsychiatric cases remained unchanged. Neuropsychiatric manifestations were added in 15.4% cases of CLD and 25% cases of CLD with PH patient. The treatment was well tolerated in 66% children without any side effects. Low WBC (6.3%) and platelet count (4.3%), vomiting (6.3%), anorexia (4.3%), loss of taste (4.3%), rash (4.3%), and proteinuria (2.1%) were found in few cases. Conclusion: Majority of the children were presented with hepatic manifestations. More than half of patients with WD treated by D-penicillamine (DP) were improved. Significant mortality was found in acute liver failure whereas neuropsychiatric presentations had persistent abnormalities. No major side effects of DP was observed in most of the cases. Early diagnosis and prompt treatment were crucial for better outcome.


  • Open Access

    Endoscopic Retrograde Cholangiopancreatography in Bangladeshi Children: Experiences and Challenges in a Developing Country

    by Rafia Rashid, Samsul Arfin, A.S.M. Bazlul Karim, Muhammad Baharul Alam, Salahuddin Mahmud

    Purpose: Although endoscopic retrograde cholangiopancreatography (ERCP) has been used for more than five decades, its applicability in Bangladeshi children has recently become more common. Therefore, this manuscript aims to describe our experience in performing ERCPs in Bangladeshi children with hepatopancreaticobiliary diseases, focusing on presenting diseases, as well as the diagnostic and therapeutic efficacy. Methods: Between 2018 and 2021, 20 children underwent 30 ERCP procedures at the Bangladesh Specialized Hospital, Dhaka. A single trained adult gastroenterologist performed all procedures using a therapeutic video duodenoscope. The indications for ERCP, diagnostic findings, therapeutic procedures, and complications were documented. Results: The median age of the study patients was 10 years (range, 1.7-15 years). Successful cannulation of the papilla was achieved in 28 procedures and failed in 2 cases. Repeated ERCP was required in seven patients. Nine patients had biliary indications and 11 had pancreatic indications. Choledocholithiasis was the most common indication for ERCP in patients with biliary disease, while chronic pancreatitis was common among patients with pancreatic indications. Pancreatic divisum was observed in only one patient. Pancreatic and biliary sphincterotomy was performed in 14 and 9 cases, respectively. A single pigtail or straight therapeutic stent was inserted in seven cases and removed in five cases. Stone extraction was performed in six procedures, and balloon dilatation was performed in five procedures. The post-procedural period for these patients was uneventful. Conclusion: We found that ERCP is a practical and successful therapeutic intervention for treating hepatopancreaticobiliary disorders in children when performed by experienced endoscopists.